Related references
Note: Only part of the references are listed.Neurologic Complications in Patients with Inflammatory Bowel Disease: Increasing Relevance in the Era of Biologics
Siddharth Singh et al.
INFLAMMATORY BOWEL DISEASES (2013)
Cutaneous manifestations of gastrointestinal disease Part II
Breck Thrash et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease
Peter L. Lakatos et al.
DIGESTION (2012)
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
Guru Trikudanathan et al.
DRUGS (2012)
Micronutrient deficiencies in inflammatory bowel disease: From A to zinc
Caroline Hwang et al.
INFLAMMATORY BOWEL DISEASES (2012)
The transition of acute to chronic bowel inflammation in spondyloarthritis
Liesbet Van Praet et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Infections and inflammatory diseases as risk factors for venous thrombosis A systematic review
Y. I. G. Vladimir Tichelaar et al.
THROMBOSIS AND HAEMOSTASIS (2012)
What is the Optimal Treatment for Anemia in Inflammatory Bowel Disease?
Alexandra J. Kent et al.
Current Drug Delivery (2012)
Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases
A. Oussalah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
John E. Eaton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Thoracic Manifestations of Inflammatory Bowel Disease
Sonia L. Betancourt et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Progress in the genetics of ankylosing spondylitis
Matthew A. Brown
BRIEFINGS IN FUNCTIONAL GENOMICS (2011)
Renal Manifestations and Complications of Inflammatory Bowel Disease
Konstantinos Oikonomou et al.
INFLAMMATORY BOWEL DISEASES (2011)
Hepatobiliary disorders and complications of inflammatory bowel disease
Preethi G. K. Venkatesh et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis
Jie Liang et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Drug-Induced Nephrotoxicity in Inflammatory Bowel Disease
Konstantinos A. Oikonomou et al.
NEPHRON CLINICAL PRACTICE (2011)
The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia
Palle Bager et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Thromboembolism in Inflammatory Bowel Disease: An Insidious Association Requiring a High Degree of Vigilance
Francesco Di Fabio et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2011)
Hepatopancreatobiliary Manifestations and Complications Associated with Inflammatory Bowel Disease
Udayakumar Navaneethan et al.
INFLAMMATORY BOWEL DISEASES (2010)
Pancreatitis in Inflammatory Bowel Diseases
C. S. Pitchumoni et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Pulmonary manifestations of inflammatory bowel disease: Case presentations and review
Benjamin Basseri et al.
JOURNAL OF CROHNS & COLITIS (2010)
Neurologic manifestations in inflammatory bowel diseases: Current knowledge and novel insights
Christos D. Zois et al.
JOURNAL OF CROHNS & COLITIS (2010)
Prevalence of anaemia in inflammatory bowel disease in Switzerland: A cross-sectional study in patients from private practices and university hospitals
Manuela Voegtlin et al.
JOURNAL OF CROHNS & COLITIS (2010)
The joint-gut axis in inflammatory bowel diseases
Lianne K. P. M. Brakenhoff et al.
JOURNAL OF CROHNS & COLITIS (2010)
Pleuropericarditis in a Patient with Inflammatory Bowel Disease: A Case Presentation and Review of the Literature
Muhanned Abu-Hijleh et al.
LUNG (2010)
Pulmonary involvement in inflammatory bowel disease
Aydin Yilmaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis A Case-control Study
Mee Joo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
Helenie Kefalakes et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Musculoskeletal Manifestations of Inflammatory Bowel Disease
Leonidas A. Bourikas et al.
INFLAMMATORY BOWEL DISEASES (2009)
Skin manifestations of inflammatory bowel disease
Shereen Timani et al.
CLINICS IN DERMATOLOGY (2008)
Extraintestinal manifestations of inflammatory bowel disease
S. Ardizzone et al.
DIGESTIVE AND LIVER DISEASE (2008)
Hepatosplenic T cell lymphoma in inflammatory bowel disease
Matthew Shale et al.
GUT (2008)
Extraintestinal manifestations of inflammatory bowel disease
Folashade A. Jose et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Tumor necrosis factor-alpha antagonists and neuropathy
Joerg-Patrick Stuebgen
MUSCLE & NERVE (2008)
Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases - A cohort study of 2402 patients
David Farhi et al.
MEDICINE (2008)
Thrombosis and inflammatory bowel disease-the role of genetic risk factors
Georgia Tsiolakidou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases
Christoph Gasche et al.
INFLAMMATORY BOWEL DISEASES (2007)
A common genetic background for inflammatory bowel disease and ankylosing spondylitis -: A genealogic study in Iceland
Bjarni Thjodleifsson et al.
ARTHRITIS AND RHEUMATISM (2007)
Autoimmune diseases induced by TNF-targeted therapies -: Analysis of 233 cases
Manuel Ramos-Casals et al.
MEDICINE (2007)
Acute paraplegia after the initiation of anti-tumour necrosis factor-a therapy for Crohn's disease
Konstantinos Vadikolias et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis
Pascal Juillerat et al.
DERMATOLOGY (2007)
Urogenital complications of Crohn's disease
Sunanda Kane
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis
J Zochling et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicyclic acid?
Androniki C. Poulou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Primary sclerosing cholangitis, inflammatory a bowel disease, and colon cancer
Ulrika Broome et al.
SEMINARS IN LIVER DISEASE (2006)
Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study
WJ Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases
Y El Miedany et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: Guidelines for clinical approach
Debbie M. Nathan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Extraintestinal manifestations in inflammatory bowel disease
Silvio Danese et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease
HJ Freeman
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Therapy Insight: vascular complications in patients with inflammatory bowel disease
IE Koutroubakis
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Primary sclerosing cholangitis
JA Talwalkar et al.
INFLAMMATORY BOWEL DISEASES (2005)
Important cutaneous manifestations of inflammatory bowel disease
LB Trost et al.
POSTGRADUATE MEDICAL JOURNAL (2005)
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
EV Loftus et al.
GUT (2005)
Ocular manifestations of inflammatory bowel disease
R Mintz et al.
INFLAMMATORY BOWEL DISEASES (2004)
Tumor necrosis factor α blockade with infliximab for refractory uveltis and scleritis
CC Murphy et al.
OPHTHALMOLOGY (2004)
Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease
H Peeters et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations
S Generini et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease - A case-control study
E Ricart et al.
INFLAMMATORY BOWEL DISEASES (2004)
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia
W Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
AGA technical review on osteoporosis in gastrointestinal diseases
CN Bernstein et al.
GASTROENTEROLOGY (2003)
Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent
T Bogenrieder et al.
DERMATOLOGY (2003)
Primary chronic interstitial nephritis in Crohn's disease
H Izzedine et al.
GASTROENTEROLOGY (2002)
Uveitis and erythema nodosum in inflammatory bowel disease: Clinical features and the role of HLA genes
TR Orchard et al.
GASTROENTEROLOGY (2002)
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis
RM Soetikno et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Risk factors for developing renal stones in inflammatory bowel disease
N McConnell et al.
BJU INTERNATIONAL (2002)
Diagnosis and treatment of urinary tract complications in Crohn's disease: An experience over 15 years
H Ben-Ami et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease
AJ Grant et al.
LANCET (2002)
Extraintestinal manifestations of inflammatory bowel disease
CYG Su et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2002)
The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)
O Palm et al.
RHEUMATOLOGY (2001)
Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy
JS Fraser et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules
M Salmi et al.
JOURNAL OF IMMUNOLOGY (2001)
Crohn's disease arthritis treated with infliximab: An open trial in four patients
MH Ellman et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2001)
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use
KR Herrlinger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Crohn's disease associated with spondyloarthropathy:: effect of TNF-α blockade with infliximab on articular symptoms
F Van den Bosch et al.
LANCET (2000)
The incidence of fracture among patients with inflammatory dowel disease - A population-based cohort study
CN Bernstein et al.
ANNALS OF INTERNAL MEDICINE (2000)
Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
DM Reid et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease
TR Orchard et al.
GASTROENTEROLOGY (2000)
Share Paper
